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partially masked or affected by proteolysis during basement
membrane fusion, and others may be replaced altogether by new
isoforms.
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Extracellular matrix components and cell differentiation
J. Zhou
domains. Although the existing data on integrin binding refer
mainly to the ubiquitous al(IV) and a2(IV) chains, we hypothe-
size that the a5(IV) and a6(IV) collagen chains may play critical
roles in cell-matrix interactions in tissues involved in the AS-DL
syndrome. This hypothesis suggests a possible link between the
matrix abnormalities and epithelial proliferation seen in polycystic
kidney disease.
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Type IV collagen is one of the major structural components of
basement membranes. The functional importance of type IV
collagen is demonstrated by the fact that mutations in one
isoform, a5(IV), lead to Alport syndrome, a severe hereditary
glomerulopathy.
Alport syndrome is the second most common kidney disorder in
humans. Affected males usually develop end-stage renal failure.
High tone deafness and ocular changes are frequent concomi-
tants. The major form of the disease is X-linked, but about 10%
of the cases have been shown to be autosomal recessive. Together
with my colleagues, I have shown that the genetic defect in
X-linked Alport syndrome involves COL4A5, the gene encoding
the a5 chain of type IV collagen. To date, over 60 mutations have
been found in the COL4A5; these vary from single base-pair
substitutions, inversions and insertions, to deletions that encom-
pass the entire COL4A5 gene.
A subset of Alport patients have concomitant diffuse leiomyo-
matosis, a smooth muscle tumor diathesis that can involve the
esophagus, trachea, bronchi, and genitalia (AS-DL). All patients
with this association have been found to have deletions extending
beyond the most 5' end of the COL4A5. Based on the hypothesis
that deletion of a gene upstream of COL4A5 explains this
association, we decided to clone the upstream genomic DNA. A
new gene that is located about 0.5 kb upstream of COL4A5 was
found and designated COL4A6,a6(IV). The protein encoded by
COL4A6 was expressed in esophagus, kidney, tracheobronchi,
and stomach. By fine genomic mapping, we showed that the
smallest deletion in AS-DL patients is only 10 to 14kb. In all cases
the deletions abolish the COL4A5 transcript and both COL4A6
transcripts.
This finding provides the first example of an association be-
tween tumors and mutations of extracellular matrix components.
How do these mutations cause AS-DL? Interactions between cells
and the underlying BM substrate play a vial role in embryonic
morphogenesis. Signals from BM proteins, transduced by inte-
grins, regulate cell growth and differentiation and influence cell
shape through effects on the cytoskeleton. Type IV collagens
contain integrin binding sites within the triple helical and NC1
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Cell-matrix interactions direct morphogenesis, differentiation,
and cell multiplication both in vivo and in vitro. Because polycystic
kidney epithelial cells have a proliferative, immature phenotype,
cell matrix interactions might either be the cause of or a target of
mutations causing PKD. To study cell-matrix interactions in PKD,
I have developed a new model system derived from the cpk
mouse, which has autosomal recessive PKD. Renal epithelial cells
from 3-week-old cystic or normal kidneys were immortalized with
SV4O T antigen. From the 68 clones obtained from these trans-
fections, 37 epithelial cell lines were selected. The criteria for
selection were that the cell lines grew as monolayers, formed cysts
when grown in collagen gels, stained with antibodies to the
epithelial-specific intermediate filament cytokeratin, and ex-
pressed the epithelial specific cell adhesion molecule E-cadherin
polarized to the lateral cell membrane.
Normal and polycystic cell lines that bound Dolichos bifioris
lectin were selected and further characterized by brush border
enzyme analysis and cAMP release in response to isoproterenol,
vasopressin, and parathyroid hormone. Using this characteriza-
tion scheme, several normal and polycystic cell lines expressing
similar markers have been identified. Several polycystic but no
normal cell lines had apical Na/K-ATPase by both confocal laser
microscopy and by selective biotinylation and immunoprecipita-
tion. These data suggest that these polycystic cell lines continue to
express the cpk defect in vitro.
Polycystic cells adhered two- to fivefold more avidly to collagen
and laminin than did normal cells. However, adhesion to fibronec-
tin was the same in polycystic and normal cells. Polycystic and
normal cell secrete the same amount of a 72 kD gelatinase, so that
the difference in adhesion cannot be explained by degradation of
the extraceullular matrix by metalloproteinases. The differences in
adhesion were found in 7 polycystic and 4 normal cell lines,
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suggesting that increased collagen binding was a characteristic of
polycystic cells rather than being a nonspecific effect of immor-
talization.
These results suggested that a specific receptor for extracellular
matrix proteins was activated or overexpressed in polycystic cells.
Data suggested that this collagenilaminin receptor was an inte-
grin. Beta-i integrins are widely expressed and are known to be
expressed in kidney epithelial cells. Therefore, if an integrin was
responsible for the adhesion of polycystic cells, it was likely to be
a beta-i integrin. An antibody to the extracellular domain of the
beta-i integrin subunit completely inhibited binding to collagen,
confirming that the integrin involved in collagen adhesion is
beta-i. Immunoprecipitation confirmed this finding and showed
that the major alpha subunit associated with the beta-i integrin
was alpha-i. Preliminary studies suggest that the number of cell
surface integrins is the same in normal and polycystic cells, despite
the two- to fivefold difference in collagen adhesion. These results
suggest that either the affinity of the integrin for collagen is
increased in polycystic cells or that the differences in adhesion are
due to cellular events involving not the initial adhesive event but
the subsequent strengthening of adhesion. Strengthening of the
initial adhesive event is well known to occur in a process that may
involve the cytoskeleton. The latter possibility is particularly
interesting in the light of the recent observation that taxol, a
microtubule stabilizing agent, prevents cyst formation in vitro and
progression of renal cystic disease in cpk mice in vivo.
References
1. WILSON PD, SHERWOOD AC, PALLA K, Du J, WATSON R, NORMAN JT:
Reversed polarity of Na/K-ATPase: Mislocation to apical plasma
membranes in polycystic kidney disease epithelia. Am J Physiol 260:
F420—F430, 1991
2. H'vms RO: Integrins: Versatility, modulation and signalling in cell
adhesion. Cell 69:11—25, 1992
3. AVNER ED, SWEENEY WE, NELSON WJ: Abnormal sodium pump
distribution during renal tubulogenesis in congenital murine polycystic
kidney disease. Proc NatI Acad Sci USA 89:7447—745 1, 1992
4. Woo DL, MIAO SYP, PELAYO JC, WooLf AS: Taxol inhibits progres-
sion of congenital polycystic kidney disease. Nature 368:75—753, 1994
5. VAN ADELSBERG JS: Polycystic kidney epithelial cell lines derived from
the C57B1/6J mouse have increased integrin-mediated adhesion to
collagen. Am J Physiol (in press)
Changes in fibroblast growth and extracellular matrix
metabolism in ADPKD
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In ADPKD, cyst development and expansion is accompanied by
progressive fibrosis of the tubulointerstitium with widening of the
tubular basement membrane, some increase in interstitial cell
number and accumulation of extracellular matrix (ECM) within
the interstitium. Disease prognosis in a number of progressive
renal diseases, including ADPKD, correlates closely with the
degree of involvement of the interstitium. This has directed
attention to understanding the biology of the cells within the
interstitium, particularly the interstitial fibroblasts.
Cultures of interstitial fibroblasts from normal and ADPKD
human kidneys can be established in vitro. Normal and ADPKD
fibroblasts exhibit different morphologies in vitro and show differ-
ent growth characteristics, with ADPKD cells having an increased
proliferative capacity. Furthermore, fibroblasts derived from end-
stage ADPKD kidneys form colonies in soft agar. However,
ADPKD fibroblasts have a finite lifespan in vitro, suggesting that
these cells are not transformed.
The increased proliferative capacity of ADPKD fibroblasts is
consistent with altered responsiveness to growth factors and/or
the production of autocrine factors. Comparison of the mitogenic
effect of a range of growth factors (EGF, PDGF, TGF-a and -f3,
acidic FGF, IGF I and II) revealed differences in the proliferative
response in normal and ADPKD fibroblasts; in particular, aFGF
is a more potent mitogen for ADPKD cells compared to their
normal counterparts. ADPKD fibroblasts produce and secrete
more aFGF than normal fibroblasts. Both cell types have high and
low affinity receptors for aFGF, and there is no apparent change
in the affinity for the high affinity (signal transducing) receptor in
ADPKD and normal fibroblasts. However, Western blotting of
homogenates from aFGF-stimulated cells using an anti-phospho-
tyrosine antibody suggests differences in the proteins phosphory-
lated following receptor-ligand interaction in the two cell types.
Taken together, these data suggest that the increased proliferative
capacity of ADPKD fibroblasts may be mediated, at least in part,
by an autocrine loop involving aFGF. Tissue homogenates from
ADPKD kidneys also contain higher levels of aFGF than from
normal kidneys. Immunostaining of tissue sections shows in-
creased immunoreactivity for aFGF in the ECM of ADPKD
kidneys, suggesting that this factor may have some in vivo
relevance in the fibrotic response associated with ADPKD. It is,
however, unlikely that a single factor is responsible for the
changes in interstitial fibroblast function in fibrosis and the role of
other factors is being investigated. ADPKD fibroblasts appear to
produce more TGF-/3. While the ubiquitous distribution and
multifunctional nature of this factor requires that such observa-
tions be interpreted with caution, TGF-f3 has been advocated as a
major fibrogenic factor in a variety of pathological disorders.
Although there is some increase in interstitial cell number in
fibrosis, the most striking aspect of the response is the accumu-
lation of ECM, Changes in the type and amount of matrix to
which the cells are exposed is likely to have profound repercus-
sions on cellular function and on the interaction between different
cell types. By immunostaining there is some increase in the
amount of collagens (types I, III and IV) and fibronectin within
the interstitium. In addition, tenascin shows abnormal localization
with focal expression in ADPKD.
Accumulation of ECM can occur as a result as a result of
increased synthesis, decreased degradation or some combination
of these processes. Northern blot analysis of levels of mRNAs
for various matrix proteins show increased expression of these
mRNAs, suggesting that an increase in synthesis contributes to
the accumulation of ECM. However, these analyses cannot dis-
tinguish between increased gene transcription and increased
stability of mRNA.
Turnover (degradation) of the ECM is tightly controlled and
regulated primarily by a group of enzymes known as the matrix
metalloproteinases (MMPs). The activity of MMPs is inhibited by
tissue inhibitors of metalloproteinases (TIMP5). Decreased deg-
radations of ECM may be due to decreased enzyme production or
